Company ProText Mobility Inc OTC Bulletin Board
Equities
US74371E1055
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update | CI |
2021 | ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Plooy Du Dylon
CEO | Chief Executive Officer | - | - |
Chairman | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Plooy Du Dylon
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,650,000 | 0 | 0 | 23.25 % |
Stock B | 0 | 511,551 | 0 | 0 | |
Stock C | 1 | 8,372,592,030 | 1,946,439,163 ( 23.25 %) | 0 | |
Stock D | 0 | 28,968 | 0 | 0 |
Company contact information
ProText Mobility, Inc.
One West Las Olas Boulevard Suite 500
33301, Fort Lauderdale
+27 79 107 0886
Sector
1st Jan change | Capi. | |
---|---|---|
-0.82% | 104B | |
+6.58% | 97.47B | |
+5.71% | 22.25B | |
-12.81% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.31% | 16.36B | |
+8.42% | 14.39B | |
+39.03% | 12.37B |
- Stock Market
- Equities
- TXTM Stock
- Stock
- Company ProText Mobility Inc